Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for KDA.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
April 30, 2026 -992.6%
January 31, 2026 -546.2%
October 31, 2025 -658.2%
July 31, 2025 -3.20K%
April 30, 2025 -11.95K%
January 31, 2025 -1.86K%
October 31, 2024 -4.65K%
July 31, 2024 -6.56K%
April 30, 2024 -831.3%
January 31, 2024 -1.35K%
October 31, 2023 -2.04K%
July 31, 2023 -15.88%
April 30, 2023
January 31, 2023
October 31, 2022 18.15%
July 31, 2022
April 30, 2022 69.10%
January 31, 2022 28.75%
October 31, 2021 22.62%
July 31, 2021 32.65%
April 30, 2021 21.03%
January 31, 2021 29.85%
October 31, 2020 24.96%
July 31, 2020 35.46%
Date Value
April 30, 2020 17.43%
January 31, 2020 20.80%
October 31, 2019 14.49%
July 31, 2019 28.33%
April 30, 2019 17.48%
January 31, 2019 20.80%
October 31, 2018 17.28%
July 31, 2018 40.48%
April 30, 2018 18.43%
January 31, 2018 20.88%
October 31, 2017 15.95%
July 31, 2017 20.76%
April 30, 2017 17.93%
January 31, 2017 70.38%
October 31, 2016 29.35%
July 31, 2016 2.68%
April 30, 2016 16.80%
January 31, 2016 10.15%
October 31, 2015 16.98%
July 31, 2015 9.88%
April 30, 2015 23.55%
January 31, 2015 30.47%
October 31, 2014 24.97%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Avricore Health, Inc. -28.89%
HLS Therapeutics, Inc. 42.90%
Spectral Medical, Inc. -186.3%
Resverlogix Corp. --
Theratechnologies, Inc. --

Gross Profit Margin (Quarterly) Related Metrics